David A. Siegel 10x Genomics, Inc. Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q4 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 1,236,200 shares of TXG stock, worth $12.2 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,236,200

Previous 363,000 240.55%

Holding current value

$12.2 Million

Previous $8.2 Million 116.58%

% of portfolio

0.04%

Previous 0.02%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$13.18 - $21.31 $11.5 Million - $18.6 Million	873,200 Added 240.55%	1,236,200 $17.8 Million
Q3 2024 Nov 14, 2024	BUY	$15.71 - $23.49 $2.23 Million - $3.33 Million	141,700 Added 64.03%	363,000 $8.2 Million
Q2 2024 Aug 14, 2024	BUY	$19.45 - $37.37 $3.87 Million - $7.43 Million	198,800 Added 883.56%	221,300 $4.3 Million
Q1 2024 May 15, 2024	BUY	$36.08 - $54.3 $811,800 - $1.22 Million	22,500 New	22,500 $844,000
Q2 2023 Aug 14, 2023	BUY	$50.96 - $58.72 $1.1 Million - $1.26 Million	21,500 New	21,500 $1.2 Million
Q4 2022 Feb 14, 2023	SELL	$24.4 - $41.3 $934,520 - $1.58 Million	-38,300 Reduced 84.36%	7,100 $258,000
Q3 2022 Nov 14, 2022	BUY	$28.48 - $52.59 $1.29 Million - $2.39 Million	45,400 New	45,400 $1.29 Million
Q2 2021 Aug 16, 2021	SELL	$134.22 - $202.37 $12.6 Million - $19 Million	-93,700 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$140.25 - $196.86 $12.1 Million - $17 Million	86,300 Added 1166.22%	93,700 $17 Million
Q4 2020 Feb 16, 2021	BUY	$126.47 - $163.7 $935,878 - $1.21 Million	7,400 New	7,400 $1.05 Million

Others Institutions Holding TXG

# of Institutions

302

Shares Held

96.5M

Call Options Held

76.4K

Put Options Held

132K

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $936M
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account